Setting occupational exposure limits for unstudied pharmaceutical intermediates using an in vitro parallelogram...

Area of Science:

• Occupational Health
• Pharmaceutical Science
• Toxicology

Background:

• Occupational exposure limits (OELs) for unstudied pharmaceutical synthetic intermediates often assume similar structure-activity and dose-response relationships as the active pharmaceutical ingredient (API).
• This assumption is frequently inaccurate, as critical active moieties may be protected or modified during synthesis, leading to potentially excessive or insufficient exposure controls.
• Overly stringent controls can create ergonomic hazards and reduce production efficiency, while inadequate controls pose health risks.

Purpose of the Study:

• To review methods for setting OELs for data-poor compounds, specifically pharmaceutical intermediates.
• To evaluate the application and limitations of in vitro assays in this context.
• To propose and demonstrate a parallelogram approach using in vitro data for establishing OELs for unstudied intermediates.

Main Methods:

• Review of existing methodologies for OELs of data-poor substances.
• Discussion of in vitro assay utility and constraints in toxicological assessments.
• Application of a parallelogram approach, comparing in vitro responses of intermediates to structurally similar, data-rich molecules (e.g., APIs).
• Identification of safeguards for pharmaceutical risk assessment uncertainties.

Main Results:

• The parallelogram approach, utilizing low-cost in vitro data, provides a feasible method for setting OELs for synthetic intermediates.
• Comparing in vitro hazard and dose-response data of intermediates to structurally similar APIs enhances the basis for OELs.
• Two examples illustrating the in vitro parallelogram approach for exposure categorization were presented.

Conclusions:

• The assumption of similar toxicity between pharmaceutical intermediates and APIs is often invalid and can lead to suboptimal occupational health and safety practices.
• A parallelogram approach using in vitro data offers a scientifically sound and practical alternative for establishing OELs for unstudied intermediates.
• This method improves risk assessment accuracy, worker safety, and production efficiency in pharmaceutical manufacturing.